News for NeuroOne Medical Technologies Corporation (NMTCD)

Feb 12, 2025 / 01:30PM GMTOperator Good day, ladies and gentlemen. Welcome to the first quarter of fiscal year 2025 financial results conference call for NeuroO

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsDave Rosa - CEORon...

**media[538744]**

Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenue from Zimmer Biomet

**media[533267]**

First Quarter Fiscal 2025 Revenue Includes a One-Time Upfront Payment of $3.0 Million in Collaboration Revenue from Zimmer Biomet and $3.2M in Product Revenue

**media[506848]**

Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Ne

**media[504958]**

NeuroOne ® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.

MELVILLE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company...

Gainers Innate Pharma S.A. (NASDAQ:IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perfo...

Gainers Trillium Therapeutics Inc. (NASDAQ:TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pf...